|
[1]
|
Shayeghi, M., Latunde-Dada, G.O., Oakhill, J.S., Laftah, A.H., Takeuchi, K., Halliday, N., et al. (2005) Identification of an Intestinal Heme Transporter. Cell, 122, 789-801. [Google Scholar] [CrossRef] [PubMed]
|
|
[2]
|
Shesh, B. and Connor, J.R. (2023) A Novel View of Ferritin in Cancer. Biochimica et Biophysica Acta (BBA)-Reviews on Cancer, 1878, Article 188917. [Google Scholar] [CrossRef] [PubMed]
|
|
[3]
|
Wang, Y., Zhang, J., Su, Y., Shen, Y., Jiang, D., Hou, Y., et al. (2020) Author Correction: G9a Regulates Breast Cancer Growth by Modulating Iron Homeostasis through the Repression of Ferroxidase Hephaestin. Nature Communications, 11, Article No. 3789. [Google Scholar] [CrossRef] [PubMed]
|
|
[4]
|
Chung, J.W., Shin, E., Kim, H., Han, H., Cho, J.Y., Choi, Y.R., et al. (2017) Hepatic Iron Overload in the Portal Tract Predicts Poor Survival in Hepatocellular Carcinoma after Curative Resection. Liver International, 38, 903-914. [Google Scholar] [CrossRef] [PubMed]
|
|
[5]
|
Buranrat, B. and Connor, J.R. (2015) Cytoprotective Effects of Ferritin on Doxorubicin-Induced Breast Cancer Cell Death. Oncology Reports, 34, 2790-2796. [Google Scholar] [CrossRef] [PubMed]
|
|
[6]
|
Salatino, A., Aversa, I., Battaglia, A.M., Sacco, A., Di Vito, A., Santamaria, G., et al. (2019) H-Ferritin Affects Cisplatin-Induced Cytotoxicity in Ovarian Cancer Cells through the Modulation of ROS. Oxidative Medicine and Cellular Longevity, 2019, Article ID: 3461251. [Google Scholar] [CrossRef] [PubMed]
|
|
[7]
|
Sukiennicki, G.M., Marciniak, W., Muszyńska, M., Baszuk, P., Gupta, S., Białkowska, K., et al. (2019) Iron Levels, Genes Involved in Iron Metabolism and Antioxidative Processes and Lung Cancer Incidence. PLOS ONE, 14, e0208610. [Google Scholar] [CrossRef] [PubMed]
|
|
[8]
|
Bian, Z., Hann, H.-W., Ye, Z., Yin, C., Wang, Y., Fang, W., et al. (2018) Ferritin Level Prospectively Predicts Hepatocarcinogenesis in Patients with Chronic Hepatitis B Virus Infection. Oncology Letters, 16, 3499-3508. [Google Scholar] [CrossRef] [PubMed]
|
|
[9]
|
Wang, F., Xu, W., Zhang, W., Xu, R., Sun, J., Zhang, G., et al. (2023) Transferrin Receptor 1 Promotes Hepatocellular Carcinoma Progression and Metastasis by Activating the mTOR Signaling Pathway. Hepatology International, 18, 636-650. [Google Scholar] [CrossRef] [PubMed]
|
|
[10]
|
Adachi, M., Kai, K., Yamaji, K., Ide, T., Noshiro, H., Kawaguchi, A., et al. (2019) Transferrin Receptor 1 Overexpression Is Associated with Tumour De‐Differentiation and Acts as a Potential Prognostic Indicator of Hepatocellular Carcinoma. Histopathology, 75, 63-73. [Google Scholar] [CrossRef] [PubMed]
|
|
[11]
|
Kim, H., Villareal, L.B., Liu, Z., Haneef, M., Falcon, D.M., Martin, D.R., et al. (2023) Transferrin Receptor‐Mediated Iron Uptake Promotes Colon Tumorigenesis. Advanced Science, 10, Article ID: 2207693. [Google Scholar] [CrossRef] [PubMed]
|
|
[12]
|
Fang, X., Hu, P., Gao, Y., Chen, C. and Xu, J. (2023) Transferrin Receptor Modulated by MicroRNA-497-5p Suppresses Cervical Cancer Cell Malignant Phenotypes. Advances in Clinical and Experimental Medicine, 33, 273-282. [Google Scholar] [CrossRef] [PubMed]
|
|
[13]
|
Zhang, Q., Chen, C., Zou, X., Wu, W., Di, Y., Li, N., et al. (2024) Iron Promotes Ovarian Cancer Malignancy and Advances Platinum Resistance by Enhancing DNA Repair via FTH1/FTL/POLQ/RAD51 Axis. Cell Death & Disease, 15, Article No. 329. [Google Scholar] [CrossRef] [PubMed]
|
|
[14]
|
Liu, B., Song, Z., Fan, Y., Zhang, G., Cao, P., Li, D., et al. (2021) Downregulation of FPN1 Acts as a Prognostic Biomarker Associated with Immune Infiltration in Lung Cancer. Aging, 13, 8737-8761. [Google Scholar] [CrossRef] [PubMed]
|
|
[15]
|
Chen, Y., Zhang, Z., Yang, K., Du, J., Xu, Y. and Liu, S. (2014) Myeloid Zinc-Finger 1 (MZF-1) Suppresses Prostate Tumor Growth through Enforcing Ferroportin-Conducted Iron Egress. Oncogene, 34, 3839-3847. [Google Scholar] [CrossRef] [PubMed]
|
|
[16]
|
Wang, L., Liu, X., You, L., Ci, Y., Chang, S., Yu, P., et al. (2018) Hepcidin and Iron Regulatory Proteins Coordinately Regulate Ferroportin 1 Expression in the Brain of Mice. Journal of Cellular Physiology, 234, 7600-7607. [Google Scholar] [CrossRef] [PubMed]
|
|
[17]
|
Basuli, D., Tesfay, L., Deng, Z., Paul, B., Yamamoto, Y., Ning, G., et al. (2017) Iron Addiction: A Novel Therapeutic Target in Ovarian Cancer. Oncogene, 36, 4089-4099. [Google Scholar] [CrossRef] [PubMed]
|
|
[18]
|
Winterbourn, C.C. (1995) Toxicity of Iron and Hydrogen Peroxide: The Fenton Reaction. Toxicology Letters, 82, 969-974. [Google Scholar] [CrossRef] [PubMed]
|
|
[19]
|
Ichijo, H., Nishida, E., Irie, K., Dijke, P.t., Saitoh, M., Moriguchi, T., et al. (1997) Induction of Apoptosis by ASK1, a Mammalian MAPKKK That Activates SAPK/JNK and P38 Signaling Pathways. Science, 275, 90-94. [Google Scholar] [CrossRef] [PubMed]
|
|
[20]
|
Han, B., Zheng, R., Zeng, H., Wang, S., Sun, K., Chen, R., et al. (2024) Cancer Incidence and Mortality in China, 2022. Journal of the National Cancer Center, 4, 47-53. [Google Scholar] [CrossRef] [PubMed]
|
|
[21]
|
Lheureux, S., Gourley, C., Vergote, I. and Oza, A.M. (2019) Epithelial Ovarian Cancer. The Lancet, 393, 1240-1253. [Google Scholar] [CrossRef] [PubMed]
|
|
[22]
|
中国抗癌协会妇科肿瘤专业委员会. 卵巢恶性肿瘤诊断与治疗指南(2021年版) [J]. 中国癌症杂志, 2021, 31(6): 490-500.
|
|
[23]
|
Rockfield, S., Raffel, J., Mehta, R., Rehman, N. and Nanjundan, M. (2017) Iron Overload and Altered Iron Metabolism in Ovarian Cancer. Biological Chemistry, 398, 995-1007. [Google Scholar] [CrossRef] [PubMed]
|
|
[24]
|
Huang, Y., Huang, J., Huang, Y., Gan, L., Long, L., Pu, A., et al. (2020) TFRC Promotes Epithelial Ovarian Cancer Cell Proliferation and Metastasis via Up-Regulation of AXIN2 Expression. American Journal of Cancer Research, 10, 131-147.
|
|
[25]
|
Rafati Rahimzadeh, M., Rafati Rahimzadeh, M., Kazemi, S., Moghadamnia, A.R., Ghaemi Amiri, M. and Moghadamnia, A.A. (2023) Iron; Benefits or Threatens (with Emphasis on Mechanism and Treatment of Its Poisoning). Human & Experimental Toxicology, 42. [Google Scholar] [CrossRef] [PubMed]
|
|
[26]
|
Li, D., Zhang, M. and Chao, H. (2021) Significance of Glutathione Peroxidase 4 and Intracellular Iron Level in Ovarian Cancer Cells— “Utilization” of Ferroptosis Mechanism. Inflammation Research, 70, 1177-1189. [Google Scholar] [CrossRef] [PubMed]
|
|
[27]
|
武福文, 洪莉. 铁死亡在卵巢癌中的机制探究[J]. 中国计划生育和妇产科, 2023, 15(7): 3-5, 13.
|
|
[28]
|
The Cancer Genome Atlas Research Network (2011) Integrated Genomic Analyses of Ovarian Carcinoma. Nature, 474, 609-615. [Google Scholar] [CrossRef] [PubMed]
|
|
[29]
|
Xu, R., Wang, W. and Zhang, W. (2023) Ferroptosis and the Bidirectional Regulatory Factor P53. Cell Death Discovery, 9, Article No. 197. [Google Scholar] [CrossRef] [PubMed]
|
|
[30]
|
Wang, Y., Hu, M., Cao, J., Wang, F., Han, J.R., Wu, T.W., et al. (2025) ACSL4 and Polyunsaturated Lipids Support Metastatic Extravasation and Colonization. Cell, 188, 412-429.E27. [Google Scholar] [CrossRef] [PubMed]
|
|
[31]
|
Kobayashi, (2010) Clear Cell Carcinoma of the Ovary: Potential Pathogenic Mechanisms (Review). Oncology Reports, 23, 1193-1203. [Google Scholar] [CrossRef] [PubMed]
|
|
[32]
|
Shigetomi, H., Imanaka, S. and Kobayashi, H. (2021) Effects of Iron-Related Compounds and Bilirubin on Redox Homeostasis in Endometriosis and Its Malignant Transformations. Hormone Molecular Biology and Clinical Investigation, 43, 187-192. [Google Scholar] [CrossRef] [PubMed]
|
|
[33]
|
Lobello, N., Biamonte, F., Pisanu, M.E., Faniello, M.C., Jakopin, Ž., Chiarella, E., et al. (2016) Ferritin Heavy Chain Is a Negative Regulator of Ovarian Cancer Stem Cell Expansion and Epithelial to Mesenchymal Transition. Oncotarget, 7, 62019-62033. [Google Scholar] [CrossRef] [PubMed]
|
|
[34]
|
Zhao, J., Guo, N., Zhang, L. and Wang, L. (2018) Serum CA125 in Combination with Ferritin Improves Diagnostic Accuracy for Epithelial Ovarian Cancer. British Journal of Biomedical Science, 75, 66-70. [Google Scholar] [CrossRef] [PubMed]
|
|
[35]
|
刘玉娇, 宋公青, 周志红. 血清癌胚抗原、甲胎蛋白、糖类抗原125及铁蛋白联合检测在卵巢癌诊断中的应用研究[J]. 临床医学工程, 2023, 30(7): 935-936.
|
|
[36]
|
Kapper, C., Oppelt, P., Arbeithuber, B., Gyunesh, A.A., Vilusic, I., Stelzl, P., et al. (2024) Targeting Ferroptosis in Ovarian Cancer: Novel Strategies to Overcome Chemotherapy Resistance. Life Sciences, 349, Article 122720. [Google Scholar] [CrossRef] [PubMed]
|
|
[37]
|
周炜程, 李锐, 张亮, 等. 基于类芬顿反应构建磁性纳米粒治疗卵巢癌: 体外实验[J]. 中国医学影像技术, 2021, 37(6): 830-835.
|
|
[38]
|
Shi, Z., Yuan, H., Cao, L. and Lin, Y. (2023) AKT1 Participates in Ferroptosis Vulnerability by Driving Autophagic Degradation of FTH1 in Cisplatin-Resistant Ovarian Cancer. Biochemistry and Cell Biology, 101, 422-431. [Google Scholar] [CrossRef] [PubMed]
|
|
[39]
|
Lopes-Coelho, F., Gouveia-Fernandes, S., Gonçalves, L.G., Nunes, C., Faustino, I., Silva, F., et al. (2015) HNF1β Drives Glutathione (GSH) Synthesis Underlying Intrinsic Carboplatin Resistance of Ovarian Clear Cell Carcinoma (OCCC). Tumor Biology, 37, 4813-4829. [Google Scholar] [CrossRef] [PubMed]
|
|
[40]
|
Zhou, H., Chen, X., Cai, L., Nan, X., Chen, J., Chen, X., et al. (2019) Erastin Reverses ABCB1-Mediated Docetaxel Resistance in Ovarian Cancer. Frontiers in Oncology, 9, Article 1398. [Google Scholar] [CrossRef] [PubMed]
|
|
[41]
|
Hong, T., Lei, G., Chen, X., Li, H., Zhang, X., Wu, N., et al. (2021) PARP Inhibition Promotes Ferroptosis via Repressing SLC7A11 and Synergizes with Ferroptosis Inducers in BRCA-Proficient Ovarian Cancer. Redox Biology, 42, Article 101928. [Google Scholar] [CrossRef] [PubMed]
|
|
[42]
|
Sandoval, T.A., Salvagno, C., Chae, C., Awasthi, D., Giovanelli, P., Marin Falco, M., et al. (2024) Iron Chelation Therapy Elicits Innate Immune Control of Metastatic Ovarian Cancer. Cancer Discovery, 14, 1901-1921. [Google Scholar] [CrossRef] [PubMed]
|
|
[43]
|
Wu, J., Bao, L., Zhang, Z. and Yi, X. (2017) Nrf2 Induces Cisplatin Resistance via Suppressing the Iron Export Related Gene SLC40A1 in Ovarian Cancer Cells. Oncotarget, 8, 93502-93515. [Google Scholar] [CrossRef] [PubMed]
|